| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $506,607 ) |
| | 2024 | 2024 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01NS110838 | Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma | 000 | 5 | NIH | 12/7/2023 | $300,153 |
| | 2024 | 2024 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01AI158543 | Incorporation of multilevel ontologies of adverse events and vaccines for vaccine safety surveillance | 000 | 5 | NIH | 12/13/2023 | $337,498 |
| | 2024 | 2023 | WILLIAM BEAUMONT HOSPITAL | 26901 BEAUMONT BLVD # 6D | SOUTHFIELD | MI | 48033-3849 | OAKLAND | USA | R01DK138839 | Sacral neuromodulation for the management of chronic pelvic pain | 000 | 1 | NIH | 4/16/2024 | $0 |
| | 2024 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R33AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 000 | 2 | NIH | 10/13/2023 | $0 |
| | 2024 | 2020 | WILLIAM BEAUMONT HOSPITAL | 26901 BEAUMONT BLVD # 6D | SOUTHFIELD | MI | 48033-3849 | OAKLAND | USA | R01HS024951 | Screening to Prophylax against C. difficile Infection (StoP CDI) | 000 | 5 | AHRQ | 12/6/2023 | -$131,044 |
| | 2024 | 2020 | WILLIAM BEAUMONT HOSPITAL | 26901 BEAUMONT BLVD # 6D | SOUTHFIELD | MI | 48033-3849 | OAKLAND | USA | R21AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 000 | 1 | NIH | 12/22/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $2,565,331 ) |
| | 2023 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01NS110838 | Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma | 000 | 4 | NIH | 12/20/2022 | $300,153 |
| | 2023 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R33AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 001 | 2 | NIH | 9/12/2023 | $200,774 |
| | 2023 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01AI158543 | Incorporation of multilevel ontologies of adverse events and vaccines for vaccine safety surveillance | 002 | 4 | NIH | 12/8/2022 | $374,998 |
| | 2023 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01NS110838 | Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma | 001 | 4 | NIH | 2/1/2023 | $33,351 |
| | 2023 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01DK135986 | The role of amphiregulin in mediating radiation cystitis in cancer survivors | 000 | 1 | NIH | 4/12/2023 | $439,160 |
| | 2023 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01NS129744 | Quinolinate-induced immune suppression in glioblastoma | 000 | 1 | NIH | 8/11/2023 | $380,000 |
| | 2023 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01DK138839 | Sacral neuromodulation for the management of chronic pelvic pain | 000 | 1 | NIH | 9/20/2023 | $562,039 |
| | 2023 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R33AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 000 | 2 | NIH | 8/15/2023 | $200,774 |
| | 2023 | 2023 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R33AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 001 | 2 | NIH | 9/12/2023 | -$200,774 |
| | 2023 | 2022 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01AI158543 | Incorporation of multilevel ontologies of adverse events and vaccines for vaccine safety surveillance | 001 | 3 | NIH | 11/15/2022 | $203,695 |
| | 2023 | 2022 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01AI158543 | Incorporation of multilevel ontologies of adverse events and vaccines for vaccine safety surveillance | 004 | 3 | NIH | 9/28/2023 | $71,161 |
| | 2023 | 2022 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | P20DK127554 | Michigan Interdisciplinary Center for Urology Research and Education (MI-CURE) | 000 | 2 | NIH | 8/28/2023 | $0 |
| | 2023 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01HS024951 | Screening to Prophylax against C. difficile Infection (StoP CDI) | 000 | 5 | AHRQ | 3/3/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $588,224 ) |
| | 2022 | 2022 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | P20DK127554 | Michigan Interdisciplinary Center for Urology Research and Education (MI-CURE) | 001 | 2 | NIH | 8/4/2022 | $294,113 |
| | 2022 | 2022 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01NS110838 | Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma | 001 | 3 | NIH | 6/24/2022 | $33,351 |
| | 2022 | 2022 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01NS110838 | Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma | 000 | 3 | NIH | 11/19/2021 | $300,153 |
| | 2022 | 2021 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | P20DK127554 | Michigan Interdisciplinary Center for Urology Research and Education (MI-CURE) | 000 | 1 | NIH | 11/4/2021 | $0 |
| | 2022 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | K01DK114334 | Cancer Survivorship Research and Training in Radiation Cystitis | 000 | 3 | NIH | 11/28/2021 | -$39,393 |
| | 2022 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R21AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 000 | 1 | NIH | 12/8/2021 | $0 |
| | 2022 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01HS024951 | Screening to Prophylax against C. difficile Infection (StoP CDI) | 000 | 5 | AHRQ | 8/30/2022 | $0 |
| | 2022 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R21AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 001 | 1 | NIH | 2/18/2022 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $540,858 ) |
| | 2021 | 2021 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01NS110838 | Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma | 000 | 2 | NIH | 11/16/2020 | $303,091 |
| | 2021 | 2021 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | P20DK127554 | Michigan Interdisciplinary Center for Urology Research and Education (MI-CURE) | 000 | 1 | NIH | 9/20/2021 | $327,117 |
| | 2021 | 2021 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01NS110838 | Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma | 001 | 2 | NIH | 1/26/2021 | $33,678 |
| | 2021 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01HS024951 | Screening to Prophylax against C. difficile Infection (StoP CDI) | 000 | 5 | AHRQ | 7/2/2021 | $0 |
| | 2021 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01HS024951 | Screening to Prophylax against C. difficile Infection (StoP CDI) | 001 | 5 | AHRQ | 9/20/2021 | $0 |
| | 2021 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R21AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 000 | 1 | NIH | 8/4/2021 | $0 |
| | 2021 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | K01DK114334 | Cancer Survivorship Research and Training in Radiation Cystitis | 000 | 3 | NIH | 5/14/2021 | $0 |
| | 2021 | 2019 | William Beaumont Hospital | 3601 W. Thirteen Mile Rd | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | C1232647 | School-Based Health Centers Capital Program | 02 | 1 | HRSA | 9/28/2021 | -$5,701 |
| | 2021 | 2019 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R13AG047010 | Congress of Urologic Research and Education on Aging UnderActive Bladder Series (CURE-UAB) | 000 | 6 | NIH | 11/12/2020 | -$5,174 |
| | 2021 | 2018 | WILLIAM BEAUMONT HOSPITAL | 3601 W 13 MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | UG1CA190002 | Beaumont NCI Community Oncology Research Program | 000 | 5 | NIH | 2/3/2021 | -$112,153 |
|
| Issue Date FY: 2020 ( Subtotal = $1,308,145 ) |
| | 2020 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | K01DK114334 | Cancer Survivorship Research and Training in Radiation Cystitis | 001 | 3 | NIH | 8/5/2020 | $54,000 |
| | 2020 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | K01DK114334 | Cancer Survivorship Research and Training in Radiation Cystitis | 000 | 3 | NIH | 6/29/2020 | $129,464 |
| | 2020 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R21AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 001 | 1 | NIH | 9/2/2020 | $181,085 |
| | 2020 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01NS110838 | Developing therapeutic strategies to elicit metabolic synthetic lethality in glioblastoma | 000 | 1 | NIH | 11/18/2019 | $341,614 |
| | 2020 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R21AG067083 | Are the impairments of arginine metabolism as found in Alzheimer's disease also present in patients developing post-operative delirium and cognitive decline? | 000 | 1 | NIH | 5/8/2020 | $148,684 |
| | 2020 | 2020 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01HS024951 | Screening to Prophylax against C. difficile Infection (StoP CDI) | 001 | 5 | AHRQ | 8/26/2020 | $453,298 |
| | 2020 | 2018 | WILLIAM BEAUMONT HOSPITAL | 3601 W. THIRTEEN MILE RD | ROYAL OAK | MI | 48073-6712 | OAKLAND | USA | R01HS024951 | Screening to Prophylax against C. difficile Infection (StoP CDI) | 000 | 3 | AHRQ | 3/24/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $741,059 ) (Continued on the next page) |
|
